American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 209,689 | 205,148 | 193,182 | 206,079 | 211,429 |
| Cost of Goods | 150,357 | 146,882 | 154,222 | 154,394 | 154,588 |
| Gross Profit | 59,332 | 58,266 | 38,960 | 51,685 | 56,841 |
| Operating Expenses | 39,415 | 33,362 | 35,941 | 38,864 | 39,225 |
| Operating Income | 20,274 | 25,786 | 3,241 | 13,215 | 18,204 |
| Interest Expense | 9,501 | 9,721 | 11,012 | 11,054 | 12,242 |
| Other Income | 1,878 | 1,118 | 1,699 | -1,127 | -30 |
| Pre-tax Income | 12,651 | 17,183 | -6,072 | 1,034 | 5,932 |
| Income Tax | -136 | 2,349 | -3,744 | -8,089 | -11,095 |
| Net Income Continuous | 12,787 | 14,834 | -2,328 | 9,123 | 17,027 |
| Minority Interests | 15,478 | 14,039 | 4,906 | 9,033 | 12,250 |
| Net Income | $-2,691 | $795 | $-7,234 | $90 | $4,777 |
| EPS Basic Total Ops | -0.08 | 0.01 | -0.23 | -0.22 | 0.11 |
| EPS Basic Continuous Ops | 0.38 | 0.45 | -0.07 | 0.28 | 0.53 |
| EPS Diluted Total Ops | -0.08 | 0.01 | -0.23 | -0.22 | 0.11 |
| EPS Diluted Continuous Ops | 0.38 | 0.43 | -0.07 | 0.30 | 0.51 |
| EPS Diluted Before Non-Recurring Items | -0.08 | 0.07 | -0.29 | 0.19 | 0.33 |
| EBITDA(a) | $30,349 | $35,567 | $12,578 | $27,142 | $29,297 |